Search

Showing "11154" results for ""

Abstinence debate finds more consensus than difference

Initiating HAART with any one of four 3 x 5 drug choices leads to longest survival in San Francisco

Two-year data continue to show promise for T-20

Drug resistant HIV present in quarter of gay men newly infected with HIV in England in 2002

CD4-guided treatment interruptions safe and cost-effective, Thai study shows

Treatment for children must become global priority, urges MSF

Low risk of serious kidney toxicity on tenofovir, but mild renal dysfunction cause for concern

South African Medicines Control Council says don’t use nevirapine alone for mums to be

Pilot study finds weekend breaks from HAART may be possible on NNRTIs

Citrus juices inactivate HIV; researcher defends investigation as possible microbicide

Cumulative time on HAART increases health risks to both mother and foetus

European study finds wasteful use of post-exposure prophylaxis

Thai nevirapine study reports final results

Four days of Combivir reduces risk of nevirapine resistance from PMTCT treatment

Fluconazole doubles nevirapine levels, greatly increasing risk of liver toxicity

Heterosexual anal sex and first sexual exposure associated with high rates of HIV transmission in African youth

Nevirapine liver toxicity associated with CD4 percentage over 25% and genetic factors, rash alone with genetic factors only

Isoniazid prophylaxis halves risk of death for children with HIV in South Africa

Receive the latest HIV research and conference news

Showing "11154" results for ""

Abstinence debate finds more consensus than difference

Initiating HAART with any one of four 3 x 5 drug choices leads to longest survival in San Francisco

Two-year data continue to show promise for T-20

Drug resistant HIV present in quarter of gay men newly infected with HIV in England in 2002

CD4-guided treatment interruptions safe and cost-effective, Thai study shows

Treatment for children must become global priority, urges MSF

Low risk of serious kidney toxicity on tenofovir, but mild renal dysfunction cause for concern

South African Medicines Control Council says don’t use nevirapine alone for mums to be

Pilot study finds weekend breaks from HAART may be possible on NNRTIs

Citrus juices inactivate HIV; researcher defends investigation as possible microbicide

Cumulative time on HAART increases health risks to both mother and foetus

European study finds wasteful use of post-exposure prophylaxis

Thai nevirapine study reports final results

Four days of Combivir reduces risk of nevirapine resistance from PMTCT treatment

Fluconazole doubles nevirapine levels, greatly increasing risk of liver toxicity

Heterosexual anal sex and first sexual exposure associated with high rates of HIV transmission in African youth

Nevirapine liver toxicity associated with CD4 percentage over 25% and genetic factors, rash alone with genetic factors only

Isoniazid prophylaxis halves risk of death for children with HIV in South Africa

Receive the latest HIV research and conference news